These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4476032)

  • 21. The phosphoprotein of attenuated measles AIK-C vaccine strain contributes to its temperature-sensitive phenotype.
    Komase K; Nakayama T; Iijima M; Miki K; Kawanishi R; Uejima H
    Vaccine; 2006 Feb; 24(6):826-34. PubMed ID: 16140429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of testing the effectiveness of live measles virus vaccine by using measles reference virus M1].
    Winkler D; Starke G; Patzwaldt HG; Plaga B
    Pharmazie; 1972 Sep; 27(9):606-8. PubMed ID: 5086359
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
    Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
    Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current problems in measles. II. Measles vaccines--recent progress].
    Ciufecu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):259-78. PubMed ID: 6438773
    [No Abstract]   [Full Text] [Related]  

  • 25. [The clinical evaluation and immunological response of a new measles vaccine].
    Moretti P; Branciaroli A; Di Battista S; Di Filippo A; Di Pietro M; Calafiore P; Di Battista C
    Minerva Pediatr; 1993 Mar; 45(3):83-6. PubMed ID: 8341231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reactogenic and immunogenic properties of a live measles vaccine made from the Leningrad-16 strain administered via the upper respiratory tract].
    Taros LIu; Smorodintsev AA
    Tr Inst Im Pastera; 1985; 62():75-8. PubMed ID: 3843367
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on the combined use of attenuated and live vaccines for measles. 1. Evaluation of vaccination with live vaccine after administration of the attenuated vaccine once or twice].
    Seki T
    Nihon Shonika Gakkai Zasshi; 1966 Dec; 70(12):1340-9. PubMed ID: 6010153
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical study on vaccination by measles vaccine].
    Sakano Y
    Nihon Shonika Gakkai Zasshi; 1966 Jul; 70(7):650-61. PubMed ID: 6005807
    [No Abstract]   [Full Text] [Related]  

  • 29. Atypical measles following immunization with killed measles vaccine.
    McLean DM; Kettyls GD; Hingston J; Moore PS; Paris RP; Rigg JM
    Can Med Assoc J; 1970 Oct; 103(7):743-4. PubMed ID: 5506110
    [No Abstract]   [Full Text] [Related]  

  • 30. [Problems concerning live measles vaccine and the control over its safety].
    Polna I
    Przegl Epidemiol; 1970; 24(1):21-30. PubMed ID: 4988185
    [No Abstract]   [Full Text] [Related]  

  • 31. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety.
    de Swart RL; Kuiken T; Fernandez-de Castro J; Papania MJ; Bennett JV; Valdespino JL; Minor P; Witham CL; Yüksel S; Vos H; van Amerongen G; Osterhaus AD
    Vaccine; 2006 Sep; 24(40-41):6424-36. PubMed ID: 16934375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of host-incorporated antigens in the immune response to measles virus.
    Isacson P
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:139-45. PubMed ID: 4313661
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
    Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
    Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
    [No Abstract]   [Full Text] [Related]  

  • 34. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

  • 35. Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine.
    Scott TF; Bonanno DE
    N Engl J Med; 1967 Aug; 277(5):248-50. PubMed ID: 6029312
    [No Abstract]   [Full Text] [Related]  

  • 36. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 37. Obtaining of measles virus haemagglutinin from strain L-16 grown in primary cell cultures.
    Dorofeyeva LV
    Acta Virol; 1975 Nov; 19(6):497. PubMed ID: 1998
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reactivity to live measles vaccine of the ESHCH strain of the Academy of Medical Sciences, RSFS].
    Tsipershteĭn MIa
    Pediatr Akus Ginekol; 1970; 4():25-6. PubMed ID: 5504822
    [No Abstract]   [Full Text] [Related]  

  • 39. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 40. Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine.
    Cerini CP; Arguedas J; Hernandez G; Frickey P; Douglas AV
    Appl Microbiol; 1974 Apr; 27(4):763-6. PubMed ID: 4856949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.